Is 7Tabz Safe? FDA Warnings on Concentrated 7-OH

By Benjamin Zohar, NCACIP — ISSUP New York Network Moderator

Medical Review: This article follows E-E-A-T principles and reflects U.S. Food and Drug Administration enforcement actions and consumer guidance current as of 2025–2026.

No — the FDA has not found 7Tabz to be safe. 7Tabz are concentrated tablets containing 7-hydroxymitragynine (7-OH), a potent kratom-derived compound that acts on the brain's opioid receptors. In June 2025, the U.S. Food and Drug Administration issued 7Tabz Retail, LLC a warning letter classifying its 7-OH products as illegal unapproved drugs, and the FDA urges consumers to avoid concentrated 7-OH products entirely because of their opioid-like effects, addiction potential, and serious safety risks including seizures, respiratory depression, and death.

Key Takeaways

7Tabz contain concentrated 7-OH, a potent opioid-receptor agonist — not ordinary kratom leaf
The FDA issued 7Tabz Retail, LLC a warning letter on June 25, 2025, calling its 7-OH products unapproved new drugs
The FDA describes concentrated 7-OH as a "novel potent opioid" and has recommended controlling it under the Controlled Substances Act
Adverse-event reports tied to concentrated 7-OH products include liver toxicity, seizures, respiratory depression, and deaths
7-OH is not approved for any medical use and is not lawful in dietary supplements or foods
Help is available — dependence on opioid-like substances is treatable

What Is 7Tabz?

7Tabz is a brand of tablet marketed as a source of concentrated 7-hydroxymitragynine, commonly shortened to 7-OH. 7-OH occurs naturally in only trace amounts in the kratom plant (Mitragyna speciosa), but products like 7Tabz contain it at concentrated, elevated levels far beyond what is found in the natural leaf. These products have been sold online and in smoke shops, gas stations, and convenience stores, and have been marketed with claims of pain relief, mood enhancement, and relaxation.

The distinction between natural kratom leaf and concentrated 7-OH matters. The FDA has been explicit that its concern is not the kratom leaf itself but the concentrated 7-OH compound, which behaves much more like a conventional opioid.

Why the FDA Considers 7-OH Dangerous

The FDA describes concentrated 7-OH products as "novel potent opioid products" that have not been proven safe or effective for any use. 7-OH binds to the same mu-opioid receptors in the brain that prescription opioids and heroin act on, which is what produces its euphoria, sedation, and pain-relieving effects — and what drives its potential for dependence and abuse.

In its consumer guidance, the FDA recommends that people avoid 7-OH products altogether, including tablets, gummies, drink mixes, and shots. The agency has stated that 7-OH is not approved for any medical use, is not lawful as a dietary supplement, and cannot be lawfully added to conventional foods, because it has not met the appropriate safety standard.

The FDA Warning Letter to 7Tabz

On June 25, 2025, the FDA's Center for Drug Evaluation and Research sent 7Tabz Retail, LLC a formal warning letter. The letter advised the company that its 7-OH products are unapproved new drugs introduced into interstate commerce in violation of the Federal Food, Drug, and Cosmetic Act.

The FDA also noted that some of these products had previously been marketed as dietary supplements, and clarified that dietary supplements containing 7-OH are considered adulterated under federal law, because there is inadequate information to provide reasonable assurance that the ingredient does not present a significant or unreasonable risk of illness or injury. The company was instructed to respond within 15 business days, with potential enforcement consequences for failing to come into compliance.

The 7Tabz letter was part of a broader FDA action announced on July 15, 2025, in which the agency issued seven warning letters to companies marketing concentrated 7-OH products.

Documented Health Risks of Concentrated 7-OH

Beyond the regulatory status, the FDA has pointed to real-world harm. In enforcement actions against companies marketing concentrated 7-OH, the agency has cited adverse-event reports linking these products to:

Liver toxicity
Seizures
Respiratory depression — slowed or stopped breathing, the mechanism by which opioids cause fatal overdose
Deaths

Because 7-OH acts on opioid receptors, the dependence and withdrawal profile resembles that of other opioids. People who use concentrated 7-OH products regularly may develop tolerance (needing more to achieve the same effect) and physical dependence, and may experience opioid-type withdrawal symptoms when they stop for more information about 7OH Withdrawal l see .Suboxone for 7-OH Addiction Withdrawal

The Move Toward Federal Scheduling

The FDA has gone beyond warning letters. The agency has recommended a scheduling action to control certain 7-OH products under the Controlled Substances Act, citing the compound's potential for abuse and its ability to bind to opioid receptors. The FDA has been careful to specify that this action targets concentrated 7-OH — not the natural kratom leaf. This signals that the regulatory environment around products like 7Tabz is tightening, not loosening.

Why "Natural" Marketing Is Misleading

Concentrated 7-OH products are often marketed using the language of natural wellness — "plant-based," "derived from kratom," "natural pain relief." This framing can create a false impression of safety. The reality, according to the FDA, is that these are concentrated opioid-receptor agonists sold without the testing, oversight, or approval required of any medicine that acts on the brain the way opioids do. The trace amount of 7-OH in a natural kratom leaf is not comparable to the elevated concentrations in these manufactured products.

Frequently Asked Questions

Is 7Tabz addictive?

7Tabz contain concentrated 7-OH, which acts on the brain's opioid receptors. Substances that act on opioid receptors carry potential for tolerance, physical dependence, and withdrawal. The FDA has identified concentrated 7-OH as having potential for abuse, which is part of why it recommended controlling it under the Controlled Substances Act.

Is 7-OH the same as kratom?

No. 7-OH occurs naturally in only trace amounts in the kratom plant. Products like 7Tabz contain concentrated, elevated levels of 7-OH that behave much more like a conventional opioid than the natural leaf does. The FDA has emphasized that its concern is concentrated 7-OH, not natural kratom leaf.

Is 7Tabz legal?

The FDA classified 7Tabz Retail, LLC's 7-OH products as unapproved new drugs being marketed illegally, and issued the company a warning letter in June 2025. 7-OH is not approved for any medical use and is not lawful in dietary supplements or foods. The FDA has also recommended scheduling certain 7-OH products under the Controlled Substances Act.

What are the dangers of concentrated 7-OH?

The FDA has cited adverse-event reports tying concentrated 7-OH products to liver toxicity, seizures, respiratory depression, and deaths. Because 7-OH acts on opioid receptors, it also carries risk of dependence and opioid-type withdrawal.

Getting Help

If you or someone you know is struggling with dependence on 7-OH, opioids, or other substances, support is available, and recovery is possible. The Substance Abuse and Mental Health Services Administration (SAMHSA) operates a free, confidential National Helpline at 1-800-662-4357, available 24/7 in English and Spanish, providing treatment referral and information services.

Understanding how relapse works in addiction recovery and what makes certain substances difficult to stop can be an important part of seeking the right support.

Sources

U.S. Food and Drug Administration. FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine. July 15, 2025.
U.S. Food and Drug Administration. Warning Letter: 7Tabz Retail, LLC — 709546. June 25, 2025.
U.S. Food and Drug Administration. FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers.
U.S. Food and Drug Administration. Products Containing 7-OH Can Cause Serious Harm (Consumer Update).

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. If you are struggling with substance use, please consult a qualified healthcare provider or addiction specialist.

About the author: Benjamin Zohar is a Nationally Certified Advanced Clinical Intervention Professional (NCACIP) and the ISSUP New York Network Moderator.